Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of 2025. Biotech and service providers have been used to a variety of headwinds over the last three years; but is this a bellwether event or an unusually positive quarter? 

On 16 September, GlobalData Healthcare will host a webinar titled “Clinical Trials surge in H1 2025: Where the real growth lies and how to stay ahead” to move beyond headline counts to get a more accurate read of trial activity. The session has been prompted by GlobalData’s clients asking to help them understand how to interpret claims by clinical trial service providers that trial initiations rose in H1 2025. 

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to GlobalData, reporting lags, shifting planned start dates, and regional differences have created a myopic viewpoint for the industry. Industry professionals and companies alike cannot wait for the clarity to come retrospectively. To address this, GlobalData analysts will use their experience and knowledge of the data trends to better understand the current landscape.

By documenting both, the scale and composition of the mid-year surge, the session will show industry leaders how GlobalData supports decision-making across the life science community. 

Key topics include: 

  • Where growth is concentrated: Analysis by therapy area, modality, geography and sponsor type to highlight segments contributing most to the increase in trials. 
  • Early indicators: How datasets can flag likely trial activity before it appears in registries. 
  • Near-term outlook: View of Q4 2025 and 2026 to help organisations plan resourcing, capacity and competitive monitoring. 

 Speakers will include;

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
  • Brooke Wilson, Director, Clinical Trials 
  • Priya Ravisekara, Senior Analyst, Clinical Trials 
  • Amanda Murphy, Head of Digital Product Management  

GlobalData will welcome you to join them for the webinar on 16 September by clicking here.  

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact